Séverine Wack

801 total citations
16 papers, 673 citations indexed

About

Séverine Wack is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Séverine Wack has authored 16 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Biotechnology. Recurrent topics in Séverine Wack's work include RNA Interference and Gene Delivery (7 papers), Virus-based gene therapy research (6 papers) and Cancer Research and Treatments (5 papers). Séverine Wack is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Virus-based gene therapy research (6 papers) and Cancer Research and Treatments (5 papers). Séverine Wack collaborates with scholars based in France, Italy and Luxembourg. Séverine Wack's co-authors include Amor Hajri, Marc Aprahamian, Patrick Couvreur, Claudie Bourgaux, Élise Lepeltier, L. Harivardhan Reddy, Andrei Maksimenko, Julie Mougin, M. K. Smith and Cindy Meyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Pharmaceutics and Molecular Therapy.

In The Last Decade

Séverine Wack

15 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Séverine Wack France	15	358	206	196	129	104	16	673
Shrirang Karve United States	15	452 1.3×	352 1.7×	280 1.4×	83 0.6×	92 0.9×	25	835
Jason Bugno United States	15	578 1.6×	275 1.3×	288 1.5×	198 1.5×	62 0.6×	19	1.1k
Prajna Mishra India	12	368 1.0×	167 0.8×	130 0.7×	158 1.2×	62 0.6×	14	697
Wenqi Jiang China	14	395 1.1×	70 0.3×	130 0.7×	183 1.4×	60 0.6×	22	796
Elizabeth E. Sweeney United States	15	235 0.7×	109 0.5×	470 2.4×	202 1.6×	93 0.9×	21	786
Rubi Mahato United States	5	418 1.2×	214 1.0×	195 1.0×	246 1.9×	76 0.7×	5	795
Shu‐Jin Li China	13	290 0.8×	110 0.5×	316 1.6×	133 1.0×	98 0.9×	22	742
Samad Muhammadnejad Iran	15	272 0.8×	83 0.4×	133 0.7×	263 2.0×	89 0.9×	58	763
Lingfei Han China	16	267 0.7×	101 0.5×	186 0.9×	91 0.7×	66 0.6×	30	574

Countries citing papers authored by Séverine Wack

Since Specialization

Citations

This map shows the geographic impact of Séverine Wack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Wack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Wack more than expected).

Fields of papers citing papers by Séverine Wack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Wack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Wack. The network helps show where Séverine Wack may publish in the future.

Co-authorship network of co-authors of Séverine Wack

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Wack. A scholar is included among the top collaborators of Séverine Wack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Wack. Séverine Wack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Maksimenko, Andrei, Franco Dosio, Julie Mougin, et al.. (2014). A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity. Proceedings of the National Academy of Sciences. 111(2). E217–26. 176 indexed citations

Caron, Joachim, Andrei Maksimenko, Séverine Wack, et al.. (2012). Improving the Antitumor Activity of Squalenoyl‐Paclitaxel Conjugate Nanoassemblies by Manipulating the Linker between Paclitaxel and Squalene. Advanced Healthcare Materials. 2(1). 172–185. 47 indexed citations

Vrignaud, Sandy, J. Hureaux, Séverine Wack, Jean‐Pierre Benoît, & Patrick Saulnier. (2012). Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. International Journal of Pharmaceutics. 436(1-2). 194–200. 60 indexed citations

Bildstein, Lucien, Véronique Marsaud, Séverine Wack, et al.. (2011). Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes. European Journal of Pharmaceutics and Biopharmaceutics. 79(3). 612–620. 24 indexed citations

Caron, Joachim, Élise Lepeltier, L. Harivardhan Reddy, et al.. (2011). Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation (Eur. J. Org. Chem. 14/2011). European Journal of Organic Chemistry. 2011(14).

Caron, Joachim, Élise Lepeltier, L. Harivardhan Reddy, et al.. (2011). Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation. European Journal of Organic Chemistry. 2011(14). 2615–2628. 21 indexed citations

Caron, Joachim, L. Harivardhan Reddy, Sinda Lepêtre‐Mouelhi, et al.. (2010). Squalenoyl nucleoside monophosphate nanoassemblies: New prodrug strategy for the delivery of nucleotide analogues. Bioorganic & Medicinal Chemistry Letters. 20(9). 2761–2764. 29 indexed citations

Wack, Séverine, et al.. (2007). K‐ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment. Cancer Science. 98(7). 1128–1136. 63 indexed citations

Wack, Séverine, et al.. (2007). Telomerase Transcriptional Targeting of Inducible Bax/TRAIL Gene Therapy Improves Gemcitabine Treatment of Pancreatic Cancer. Molecular Therapy. 16(2). 252–260. 15 indexed citations

10.

Deharvengt, Sophie J., et al.. (2007). Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine. International Journal of Oncology. 30(6). 1397–406. 22 indexed citations

11.

Palissot, Valérie, Nasséra Aouali, Séverine Wack, et al.. (2007). Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines. International Journal of Oncology. 30(3). 573–82. 34 indexed citations

12.

Deharvengt, Sophie J., Séverine Wack, Marc Aprahamian, & Amor Hajri. (2004). Transcriptional tumor‐selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy. The Journal of Gene Medicine. 7(5). 672–680. 14 indexed citations

13.

Deharvengt, Sophie J., et al.. (2004). Suicide Gene/Prodrug Therapy for Pancreatic Adenocarcinoma by E. Coli Purine Nucleoside Phosphorylase and 6-Methylpurine 2′-deoxyriboside. Pancreas. 28(2). e54–e64. 16 indexed citations

14.

Hajri, Amor, Séverine Wack, Pierre Lehn, et al.. (2003). Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes. Cancer Gene Therapy. 11(1). 16–27. 23 indexed citations

15.

Wack, Séverine, Amor Hajri, F. Heisel, et al.. (2003). Feasibility, sensitivity, and reliability of laser-induced fluorescence imaging of green fluorescent protein-expressing tumors in vivo. Molecular Therapy. 7(6). 765–773. 21 indexed citations

16.

Hajri, Amor, Séverine Wack, Cindy Meyer, et al.. (2002). In Vitro and In Vivo Efficacy of Photofrin® and Pheophorbide a, a Bacteriochlorin, in Photodynamic Therapy of Colonic Cancer Cells¶. Photochemistry and Photobiology. 75(2). 140–140. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact